Scienture Holdings, Inc. (SCNX)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
Market Cap: $4.76M
Last updated: Nov 17, 2026 at 11:04 AM ET
Scienture Holdings, Inc. (SCNX) Financials: Revenue, Profit and Cash Flow
Scienture Holdings reported revenue of $431.61K for the fiscal year ended Dec 31, 2025, up 215.9% from the year before. That year, net income was -$41.51M with a net margin of -9618.0%, operating cash flow was -$13.38M and free cash flow was -$13.38M. The quarter ended Sep 30, 2026 had revenue of $1.25M and net income of -$6.01M.
Revenue and Margins
Over the 8 years to Dec 2025, revenue fell from $2.93M, a compound annual decline of 21.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $431.61K | +215.9% | 76.8% | -9867.9% | -9618.0% |
| Dec 2024 | $136.64K | -90.0% | 4.4% | -10758.7% | 6634.7% |
| Dec 2023 | $1.36M | -86.7% | 3.6% | -322.4% | -1308.3% |
| Dec 2022 | $10.25M | +3.6% | 53.8% | -28.4% | -38.1% |
| Dec 2021 | $9.89M | -42.2% | 48.0% | -53.5% | -53.8% |
| Dec 2020 | $17.12M | +130.3% | 33.3% | -14.6% | -14.8% |
| Dec 2019 | $7.44M | +94.1% | 65.5% | 1.7% | -3.8% |
| Dec 2018 | $3.83M | +30.7% | 88.3% | -2.3% | 0.2% |
| Dec 2017 | $2.93M | N/A | 100.0% | 13.5% | 9.9% |
| Dec 2016 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $431.61K | $136.64K | $1.36M | $10.25M | $9.89M | $17.12M | $7.44M | $3.83M | $2.93M | $0 |
| Cost of revenue | $100.13K | $130.64K | $1.31M | $4.73M | $5.14M | $11.42M | $2.57M | $449.05K | $0 | $0 |
| Gross profit | $331.48K | $6.00K | $49.03K | $5.52M | $4.75M | $5.71M | $4.87M | $3.38M | $2.93M | $0 |
| Research and development | $1.96M | $2.24M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$42.59M | -$14.70M | -$4.40M | -$2.92M | -$5.29M | -$2.51M | $125.22K | -$87.62K | $395.10K | -$1.01M |
| Net income | -$41.51M | $9.07M | -$17.84M | -$3.91M | -$5.32M | -$2.54M | -$284.43K | $9.04K | $288.98K | -$2.76M |
| EBITDA | -$35.73M | N/A | N/A | -$1.89M | -$5.15M | -$2.40M | $219.96K | $74.17K | $483.74K | -$933.57K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.25M | $343.64K | $56.33K | -$168.70K | $590.05K | $0 | $10.26K | $53.08K | $64.86K | $18.70K | $0 | $111.70K |
| Gross profit | $1.02M | $335.78K | $53.85K | -$243.81K | $574.62K | $0 | $673 | $2.83K | $3.88K | -$703 | $0 | -$130.92K |
| Operating income | -$5.72M | -$2.70M | -$3.51M | -$29.50M | -$4.36M | -$5.16M | -$3.57M | -$4.21M | -$3.50M | -$1.50M | -$5.49M | -$2.23M |
| Net income | -$6.01M | -$2.82M | -$3.40M | -$28.12M | -$3.61M | -$6.72M | -$3.06M | -$7.16M | -$3.18M | -$1.83M | $21.25M | -$11.67M |
Balance Sheet
As of Dec 2025, the balance sheet showed $6.66M in cash and equivalents and no debt.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $84.18M | $104.85M | $12.53M | $3.71M | $5.77M | $9.79M | $5.57M | $2.23M | $617.48K | $0 |
| Current assets | $7.92M | $6.31M | $2.75M | $2.09M | $4.37M | $9.22M | $3.80M | $1.47M | $607.48K | $0 |
| Cash and equivalents | $6.66M | $308.10K | $314 | $1.09M | $3.12M | $5.92M | $2.87M | $869.56K | $183.91K | $14.68K |
| Total liabilities | $14.06M | $25.78M | $11.99M | $3.37M | $2.00M | $1.11M | $1.43M | $1.38M | $929.41K | $0 |
| Short-term debt | $0 | $2.70M | $0 | $166.67K | $0 | $225.00K | $0 | $321.50K | $262.31K | $0 |
| Long-term debt | $0 | $612.27K | $0 | $333.33K | $0 | N/A | $225.00K | $522.55K | $404.05K | $0 |
| Shareholder equity | $70.12M | $79.07M | $542.35K | $763.14K | $3.77M | $8.68M | $4.14M | $844.67K | -$311.93K | $0 |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $87.18M | $87.73M | $80.66M | $84.18M | $104.83M | $104.29M | $106.36M | $104.85M | $94.26M | $14.85M | $16.74M | $21.65M |
| Total liabilities | $28.44M | $23.63M | $13.84M | $14.06M | $22.16M | $26.43M | $25.20M | $25.78M | $9.13M | $3.06M | $3.12M | $10.09M |
| Cash and equivalents | $4.75M | $8.19M | $3.54M | $6.66M | $355.69K | $15.39K | $2.05M | $308.10K | $579.10K | $7.72M | $3.50M | $34.03K |
| Shareholder equity | $58.74M | $64.10M | $66.82M | $70.12M | $82.67M | $77.86M | $81.16M | $79.07M | $85.13M | $11.79M | $13.62M | $11.56M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.38M | -$14.27M | -$2.23M | -$1.56M | -$2.57M | -$2.21M | $141.78K | $273.39K | $171.67K | -$3.68M |
| Capital expenditures | $0 | $12.00K | $0 | $0 | $22.60K | $37.51K | $82.25K | $15.01K | $0 | $0 |
| Free cash flow | -$13.38M | -$14.28M | -$2.23M | -$1.56M | -$2.59M | -$2.25M | $59.52K | $258.38K | $171.67K | -$3.68M |
| Dividends paid | $0 | $14.86M | $0 | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | $732.36K | $0 | N/A | N/A | N/A |
| Investing cash flow | $0 | $27.55M | -$275.72K | -$427.85K | -$22.60K | -$37.51K | -$332.25K | -$265.28K | $0 | $0 |
| Financing cash flow | $19.73M | -$12.98M | $1.41M | -$35.17K | -$208.18K | $5.30M | $2.19M | $677.54K | -$2.44K | $621.39K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.46M | -$3.13M | -$2.92M | -$5.18M | -$3.21M | -$2.03M | -$2.96M | -$2.91M | -$5.39M | $4.22M | -$10.19M | -$1.02M |
| Capital expenditures | N/A | N/A | $5 | $3 | $5 | $3 | $3 | $3 | $12.00K | $5 | $3 | $2 |
| Free cash flow | N/A | N/A | -$2.92M | -$5.18M | -$3.21M | -$2.03M | -$2.96M | -$2.91M | -$5.40M | $4.22M | -$10.19M | -$1.02M |
Frequently Asked Questions About SCNX
What is Scienture Holdings' annual revenue?
Scienture Holdings reported revenue of $431.61K for the fiscal year ended Dec 31, 2025.
How fast is Scienture Holdings' revenue growing?
Revenue was up 215.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -65.2%.
Is Scienture Holdings profitable?
No. Scienture Holdings reported net income of -$41.51M for the fiscal year ended Dec 31, 2025, with a net margin of -9618.0%.
How much free cash flow does SCNX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$13.38M minus capital expenditures of $0 produced free cash flow of -$13.38M.
How much debt does Scienture Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $0 and cash and equivalents of $6.66M.
SCNX pages: Overview, Earnings, Forecast, Financials, Competitors